Capital Pro-Égaux Inc instigates legal action in connection with recent settlements

Capital Pro-Égaux Inc instigates legal action in connection with recent 
LACHENAIE, QC, Dec. 20, 2013 /CNW Telbec/ - Capital Pro-Égaux Inc. (the 
"Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique 
d'usinage Sinlab Inc. ("Sinlab"), has filed an action for damages it believes 
are the result of professional malpractice of certain former legal counsels of 
Sinlab in connection with matters pertaining to the recently announced 
settlements involving Delcam USA, Inc. and Delcam Holdings, Inc., Cagenix, 
Inc., Dentsply International Inc. and the Nobel Entities, comprised of Nobel 
Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel 
Biocare Deutschland GmbH; Nobel Biocare Canada, Inc.; Biocad Médical Inc.; 
Nobel Biocare USA, LLC; and Nobel Biocare Procera, LLC. 
Caution regarding forward-looking statements 
This news release contains certain forward-looking statements regarding the 
Company's expectation of future events, including potential claims and legal 
proceedings. Such expectations are based on certain assumptions based on 
currently available information. If these assumptions prove incorrect, actual 
results may differ materially from those contemplated by the forward-looking 
statements contained in this press release. Factors that could lead actual 
results to differ include, amongst others, factors that may impact claims and 
legal proceedings, such as interpretation of factual matters, time and money 
involved in undertaking legal proceedings, uncertainty as to the final result 
and other risks. The Company disclaims any intention or obligation to publicly 
update or revise any forward-looking statements, whether as a result of new 
information, future events or otherwise, other than as required by securities 
About Pro-Égaux Inc. 
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab 
Inc., is a company based in Lachenaie, Quebec, specializing mainly in the 
conception and design of titanium products to be used in the dental prosthesis 
restoration industry. 
Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as 
that term is defined in the policies of NEX and the TSX Venture Exchange) 
accepts responsibility for the adequacy or accuracy of this release.

SOURCE  Capital Pro-Égaux Inc. 
Capital Pro-Égaux Inc. Pierre Désormeau President Fax: (450) 226-1923 
To view this news release in HTML formatting, please use the following URL: 
CO: Capital Pro-Égaux Inc.
ST: Quebec
-0- Dec/20/2013 23:29 GMT
Press spacebar to pause and continue. Press esc to stop.